Âé¶¹´«Ã½

Our Âé¶¹´«Ã½ on Âé¶¹´«Ã½

Âé¶¹´«Ã½: 680270718a753_fsb270458-toc-0001-m.jpg

Protein That Stops Cell Division Could Serve as a Biomarker or Therapeutic Target for Liver Disease

A stress-response protein, CDKN1A, may serve as a biomarker or therapeutic target for MASLD, new research in The FASEB Journal shows. Its expression correlated with disease severity across patient datasets and animal models.
18-Apr-2025 4:50 PM EDT Add to Favorites

Âé¶¹´«Ã½: 67f93ee862d53_fba2.v7.4.cover.jpg

FASEB BioAdvances April 2025 Issue: Exploring the Intersection of Environmental Factors, Innovative Treatments, and Precision Medicine

The April 2025 issue of FASEB BioAdvances delves into the effects of global warming on obesity, innovative treatments for hypertension and kidney injury, gene recombination in neural tissues, and the future of precision medicine through AI and...
11-Apr-2025 5:55 PM EDT Add to Favorites

Probiotic Bacteria Regulate Gut Hormones

Researchers found that probiotic bacteria Limosilactobacillus reuteri can regulate gut hormones, revealing new insights into their potential health benefits. The study, published in The FASEB Journal, suggests probiotics may have systemic effects...
18-Mar-2025 9:45 AM EDT Add to Favorites


See All News

Our Experts on News

Our experts are coming soon...

About

FASEB is a federation comprised of 22 scientific member societies representing 110,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to member societies and their members. www.faseb.org

Experts

Twitter

close
0.32894